apis.yml

aid: oricell
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/oricell.png
name: oricell
description: Oricell Therapeutics (原启生物) is a Shanghai-based clinical-stage biopharmaceutical
  company developing cell-based immunotherapies for cancer, including GPC3-targeted CAR-T (Ori-C101)
  for advanced liver cancer and GPRC5D-targeted CAR-T (OriCAR-017) for relapsed/refractory multiple
  myeloma. It operates proprietary OriAb antibody-discovery, OriCAR T-cell persistence, and cell-manufacturing
  (CMC) platforms. Backed by Qiming Venture Partners. As a clinical-stage biotech it publishes no public
  developer API, documentation, or technical developer surface; this profile is retained as a company
  record in the API Evangelist network.
url: https://raw.githubusercontent.com/api-evangelist/oricell/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- qiming
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Cell Therapy
- Immunotherapy
- Oncology
- CAR-T
- Healthcare
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://oricell.com
x-enrichment:
  date: '2026-07-20'
  status: nochange
  artifacts_added: 0
  pass: local-v1